Unknown

Dataset Information

0

An integrated biometric voice and facial features for early detection of Parkinson's disease.


ABSTRACT: Hypomimia and voice changes are soft signs preceding classical motor disability in patients with Parkinson's disease (PD). We aim to investigate whether an analysis of acoustic and facial expressions with machine-learning algorithms assist early identification of patients with PD. We recruited 371 participants, including a training cohort (112 PD patients during "on" phase, 111 controls) and a validation cohort (74 PD patients during "off" phase, 74 controls). All participants underwent a smartphone-based, simultaneous recording of voice and facial expressions, while reading an article. Nine different machine learning classifiers were applied. We observed that integrated facial and voice features could discriminate early-stage PD patients from controls with an area under the receiver operating characteristic (AUROC) diagnostic value of 0.85. In the validation cohort, the optimal diagnostic value (0.90) maintained. We concluded that integrated biometric features of voice and facial expressions could assist the identification of early-stage PD patients from aged controls.

SUBMITTER: Lim WS 

PROVIDER: S-EPMC9617232 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

An integrated biometric voice and facial features for early detection of Parkinson's disease.

Lim Wee Shin WS   Chiu Shu-I SI   Wu Meng-Ciao MC   Tsai Shu-Fen SF   Wang Pu-He PH   Lin Kun-Pei KP   Chen Yung-Ming YM   Peng Pei-Ling PL   Chen Yung-Yaw YY   Jang Jyh-Shing Roger JR   Lin Chin-Hsien CH  

NPJ Parkinson's disease 20221029 1


Hypomimia and voice changes are soft signs preceding classical motor disability in patients with Parkinson's disease (PD). We aim to investigate whether an analysis of acoustic and facial expressions with machine-learning algorithms assist early identification of patients with PD. We recruited 371 participants, including a training cohort (112 PD patients during "on" phase, 111 controls) and a validation cohort (74 PD patients during "off" phase, 74 controls). All participants underwent a smartp  ...[more]

Similar Datasets

| S-EPMC8251040 | biostudies-literature
| S-EPMC9253091 | biostudies-literature
| S-EPMC4501841 | biostudies-literature
| S-EPMC5549905 | biostudies-other
| S-EPMC6614282 | biostudies-literature
| S-EPMC5786318 | biostudies-literature
| S-EPMC8677804 | biostudies-literature
| S-EPMC5771326 | biostudies-literature
| S-EPMC4540566 | biostudies-literature
| S-EPMC7935511 | biostudies-literature